News About: Pharm. Industry
Local drugmakers seeking to tackle falling revenue
A plethora of major issues are slated to affect Korean industries this year, including a massive price -cut plan starting April.
The forecast of rocky pharmaceutical markets could lead to uncertain financing condit...
CKD, Roche Korea forge partnership
Chong Kun Dang Pharmaceutical announced Tuesday that it has inked a business alliance agreement with Roche Korea.
Under the deal, CKD will be in charge of selling six Roche drugs using its extensive domestic distri...
Mvix S takes on Viagra, Cialis
SK Chemicals is enjoying brisk sales of its anti-impotence drug, Mvix S due to its new oral disintegrating film as a new dosage form.
The company said that the annual sales of Mvix S is expected to surge 30 billion...
LG Life Sciences targets 400 billion won in 2012 sales
LG Life Sciences aims to achieve 400 billion won in sales this year with the intention of emerging as one of research oriented companies, a company executive said Tuesday.
“We will reach 400 billion won in this yea...
New drug pricing policy squeezing drug firms
The government’s plan to cut drug prices by an average of 14 percent starting April has triggered vehement protests from the domestic pharmaceutical community.
A report released by the Korea Pharmaceutical Manufac...
Handok, Mitsubishi Tanabe announces licensing agreement for novel DPP-4 agent
Handok Pharma and Mitsubishi Tanabe Pharma announced Tuesday the execution of a license agreement granting Hanmi to market Mitsubishi Tanabe’s new dipeptidyl peptidase 4 (DPP-4 agent) MP-513 (teneligliptin) for the tr...
Hanmi, Spectrum enter agreement over neutropenia treatment
Hanmi Pharmaceutical said Tuesday that it has signed a co-development and commercialization Agreement with the US based Spectrum Pharmaceuticals on Hanmi’s new biopharmaceutical LAPS-GCSF (HM10460A/neutropenia drug)....
Huons gets KFDA approval for combination drug
Huons and CTC Bio said Tuesday that the Korea Food and Drug Administration has given the green light to Arigrel, which combines the two most commonly prescribed medicines, clopidogrel and aspirin, for the treatment of...
Celltrion’s international trademark applications top 23 in 2011
Biotech company Celltrion Inc. filed 23 Madrid system based trademark applications last year in an effort to protect its own medicines in the international arena, according to the Korean Intellectual Property Office (...
Can Rhu be renamed as KPMA chairman
Attention has been drawn on whether Rhu Duk-hee , chairman of the incumbent chairman of the Korea Pharmaceutical Manufacturers Association, could be re-appointed at the next month's general meeting.
Most of KPMA ex...
